secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKWELL MEDICAL, INC. (RMTI)
CIK:        0001041024
Form:       8-K
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0001104659-25-046957
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rockwell Medical Q1 net sales $18.9M (-17% YoY); net loss improves to $1.5M
---------------------------------------------------------------------------

- Net sales fell 17% to $18.9M, driven by largest customer transitioning to another supplier.
- Received a one-time non-refundable payment of $0.9M from that customer to ensure supply continuity.
- Net loss improved 12% to $1.5M ($0.04 loss per share) vs $1.7M in Q1 2024.
- Adjusted EBITDA was -$0.4M; cash and investments $17.3M, down $4.3M from year-end 2024.
- Reaffirmed 2025 guidance: net sales $65M-$70M, gross margin 16%-18%, adjusted EBITDA -$0.5M to $0.5M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1041024/000110465925046957/0001104659-25-046957-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1041024/000110465925046957/tm2514651d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-046957

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer